Brief: Relay Therapeutics Q4 Net Income USD -76.004 Million
26/02/2025 21:05
Feb 26 (Reuters) - Relay Therapeutics Q4 operating expenses USD 84.979 million. Q4 operating income USD -84.979 million Q4 basic EPS USD -0.45
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock